SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001583771-23-000007
Filing Date
2023-05-12
Accepted
2023-05-12 16:17:57
Documents
68
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q hepa-20230331.htm   iXBRL 10-Q 851733
2 EX-31.1 hepa-q1202310xqxexx311.htm EX-31.1 9925
3 EX-31.2 hepa-q1202310xqxexx312.htm EX-31.2 9778
4 EX-32.1 hepa-q1202310xqxexx321.htm EX-32.1 4764
5 EX-32.2 hepa-q1202310xqxexx322.htm EX-32.2 4748
11 hepa-20230331_g1.jpg GRAPHIC 10809
  Complete submission text file 0001583771-23-000007.txt   4733630

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hepa-20230331.xsd EX-101.SCH 37521
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT hepa-20230331_cal.xml EX-101.CAL 39076
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hepa-20230331_def.xml EX-101.DEF 183428
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hepa-20230331_lab.xml EX-101.LAB 455144
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hepa-20230331_pre.xml EX-101.PRE 304287
62 EXTRACTED XBRL INSTANCE DOCUMENT hepa-20230331_htm.xml XML 649061
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
Hepion Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36856 | Film No.: 23916039
SIC: 2834 Pharmaceutical Preparations